TGTX

TG Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$33.53

Market Cap

$5.35B

Beta

1.75

P/E

12.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+87.32%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y+500.00%

P/E Ratio12.2

PEG Ratio0.02

FCF Yield-0.47%

Debt / Equity0.40

Interest Coverage4.6x

No credit card required

Already have an account? Sign in to view the full analysis for TGTX.